Upgrades:
JPMorgan Chase & Co. upgraded shares of Abbott
Laboratories (NYSE:ABT) from a neutral rating to an overweight rating in a
research note released on Tuesday morning. JPMorgan Chase & Co. currently
has $60.00 price objective on the healthcare product maker’s stock. Read more …
Abbott Laboratories (NYSE:ABT) was upgraded by equities
researchers at Morgan Stanley from an “equal weight” rating to an “overweight”
rating in a research report issued on Tuesday. The firm presently has a $67.00
target price on the healthcare product maker’s stock. Morgan Stanley’s target
price would suggest a potential upside of 13.71% from the stock’s current
price. Read more …
Bank of America upgraded shares of Baxter International
(NYSE:BAX) from a neutral rating to a buy rating in a research note issued to
investors on Tuesday, Marketbeat Ratings reports. Read more …
Baxter International (NYSE:BAX) was upgraded by analysts at
JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a
research report issued on Tuesday. Several other research analysts have also
recently issued reports on the company. Zacks Investment Research cut Baxter
International from a “buy” rating to a “hold” rating in a research report on
Tuesday, December 26th. Bank of America reaffirmed a “hold” rating on shares of
Baxter International in a research report on Wednesday, November 22nd. Royal
Bank of Canada reaffirmed a “hold” rating and set a $66.00 price objective on
shares of Baxter International in a research report on Wednesday, November
22nd. Stifel Nicolaus reaffirmed a “hold” rating and set a $65.00 price
objective on shares of Baxter International in a research report on Thursday,
October 26th. Finally, Barclays lifted their price objective on Baxter
International from $70.00 to $73.00 and gave the company an “overweight” rating
in a research report on Thursday, October 26th. Seven research analysts have
rated the stock with a hold rating, eight have assigned a buy rating and two
have given a strong buy rating to the company’s stock. The stock currently has
a consensus rating of “Buy” and a consensus price target of $68.64. Read more …

Vertical Research upgraded shares of Emerson Electric
(NYSE:EMR) from a hold rating to a buy rating in a research note released on
Tuesday, The Fly reports. Several other research analysts have also weighed in
on EMR. Zacks Investment Research upgraded shares of Emerson Electric from a
sell rating to a hold rating in a research report on Tuesday, October 31st.
Morgan Stanley restated an equal weight rating and set a $67.00 target price
(up from $64.00) on shares of Emerson Electric in a research report on Monday,
October 2nd. Cowen restated a buy rating and set a $72.00 target price on
shares of Emerson Electric in a research report on Wednesday, December 20th.
Citigroup set a $61.00 target price on shares of Emerson Electric and gave the
stock a sell rating in a research report on Tuesday, November 28th. Finally,
Stifel Nicolaus restated a buy rating and set a $75.00 target price on shares
of Emerson Electric in a research report on Monday, December 11th. Three
investment analysts have rated the stock with a sell rating, eleven have
assigned a hold rating and five have assigned a buy rating to the stock. The
stock has an average rating of Hold and a consensus target price of $65.86. Read more …
Bank of America upgraded shares of International Paper
(NYSE:IP) from a neutral rating to a buy rating in a research report sent to
investors on Tuesday morning. They currently have $66.00 target price on the
basic materials company’s stock. Other research analysts have also recently issued
reports about the stock. BMO Capital Markets reissued a buy rating and set a
$62.00 price target on shares of International Paper in a research report on
Friday, November 24th. Royal Bank of Canada reissued a buy rating and set a
$65.00 price target on shares of International Paper in a research report on
Monday, October 23rd. Stephens started coverage on shares of International
Paper in a research report on Tuesday, October 24th. Read more …
Robert W. Baird upgraded shares of L Brands (NYSE:LB) from a
neutral rating to an outperform rating in a research note released on Tuesday,
Marketbeat reports. Robert W. Baird currently has $70.00 price target on the
specialty retailer’s stock, up from their prior price target of $60.00. A number
of other brokerages have also recently issued reports on LB. BMO Capital
Markets set a $56.00 target price on L Brands and gave the stock a hold rating
in a report on Tuesday, December 19th. Morgan Stanley restated an overweight
rating and issued a $70.00 target price on shares of L Brands in a report on
Thursday, December 14th. CIBC reiterated a hold rating and set a $60.00 price
target on shares of L Brands in a report on Friday, December 8th. Telsey
Advisory Group lifted their price target on L Brands from $60.00 to $64.00 and
gave the company an outperform rating in a report on Monday, December 4th.
Finally, B. Riley reiterated a buy rating and set a $58.00 price target on
shares of L Brands in a report on Wednesday, November 29th. Six equities research
analysts have rated the stock with a sell rating, twenty have given a hold
rating and twelve have given a buy rating to the company. The stock presently
has an average rating of Hold and an average target price of $51.80. Read more…
Bank of America upgraded shares of Medtronic (NYSE:MDT) from
a neutral rating to a buy rating in a research report released on Tuesday
morning. Several other equities analysts also recently weighed in on MDT. Zacks
Investment Research raised shares of Medtronic from a sell rating to a hold
rating in a research note on Wednesday, September 6th. Jefferies Group reissued
a buy rating and issued a $96.00 price target on shares of Medtronic in a
research note on Thursday, September 28th. SunTrust Banks reissued a buy rating
and issued a $96.00 price target on shares of Medtronic in a research note on
Monday, October 2nd. Wells Fargo & Co downgraded shares of Medtronic from
an outperform rating to a market perform rating and decreased their price
target for the stock from $93.00 to $83.00 in a research note on Monday,
October 9th. Finally, Royal Bank of Canada decreased their price target on
shares of Medtronic from $90.00 to $85.00 and set an outperform rating on the
stock in a research note on Monday, October 9th. Two investment analysts have
rated the stock with a sell rating, ten have assigned a hold rating and fifteen
have assigned a buy rating to the company. The stock has a consensus rating of
Hold and a consensus target price of $88.64. Read more …
Eaton (NYSE:ETN) was upgraded by Robert W. Baird from a
“neutral” rating to an “outperform” rating in a report issued on Wednesday. The
brokerage presently has a $92.00 price target on the industrial products
company’s stock, up from their prior price target of $82.00. Robert W. Baird’s
target price would suggest a potential upside of 16.66% from the company’s
current price. Several other equities research analysts also recently issued
reports on ETN. ValuEngine upgraded shares of Eaton from a “hold” rating to a
“buy” rating in a research note on Friday, September 15th. Morgan Stanley
restated an “overweight” rating and issued a $88.00 price objective (up
previously from $87.00) on shares of Eaton in a research note on Monday,
October 2nd. Stifel Nicolaus restated a “hold” rating and issued a $82.00 price
objective on shares of Eaton in a research note on Thursday, October 12th.
Citigroup raised their price objective on shares of Eaton from $88.00 to $90.00
and gave the stock a “buy” rating in a research note on Friday, October 13th.
Finally, Bank of America downgraded shares of Eaton from a “buy” rating to an
“underperform” rating in a research note on Tuesday, October 17th. Four
analysts have rated the stock with a sell rating, ten have assigned a hold
rating and eight have issued a buy rating to the stock. The company currently
has an average rating of “Hold” and an average price target of $83.43. Read more …
International Business Machines (NYSE:IBM) was upgraded by
Royal Bank of Canada from a “sector perform” rating to an “outperform” rating
in a research note issued on Wednesday. The brokerage currently has a $180.00
price target on the technology company’s stock, up from their prior price
target of $160.00. Royal Bank of Canada’s price objective suggests a potential
upside of 11.32% from the stock’s previous close. The analysts noted that the
move was a valuation call. Other equities analysts also recently issued reports
about the stock. Drexel Hamilton reiterated a “buy” rating and set a $200.00
price objective on shares of International Business Machines in a research note
on Tuesday, October 17th. Stifel Nicolaus reiterated a “buy” rating and set a
$182.00 price objective on shares of International Business Machines in a
research note on Friday, October 6th. ValuEngine upgraded shares of
International Business Machines from a “hold” rating to a “buy” rating in a
research note on Monday, October 2nd. Vetr upgraded shares of International
Business Machines from a “hold” rating to a “buy” rating and set a $164.53
price objective on the stock in a research note on Tuesday, October 24th.
Finally, Pivotal Research initiated coverage on shares of International
Business Machines in a research note on Friday, October 27th. They set a “buy”
rating and a $180.00 price objective on the stock. Eight analysts have rated
the stock with a sell rating, sixteen have assigned a hold rating and twelve
have assigned a buy rating to the stock. The company currently has an average
rating of “Hold” and a consensus target price of $160.01. Read more …
Royal Bank of Canada upgraded shares of United Technologies
(NYSE:UTX) from a sector perform rating to an outperform rating in a research
report report published on Wednesday morning. The analysts noted that the move
was a valuation call. Other research analysts also recently issued research
reports about the stock. Bank of America restated a buy rating and set a
$140.00 price objective on shares of United Technologies in a research report
on Wednesday, September 6th. Deutsche Bank lowered their price objective on
shares of United Technologies from $125.00 to $120.00 and set a hold rating on
the stock in a research report on Wednesday, September 6th. Vertical Research
downgraded shares of United Technologies from a buy rating to a hold rating and
set a $125.00 price objective on the stock. in a research report on Tuesday,
September 5th. Cowen downgraded shares of United Technologies from an
outperform rating to a market perform rating and lowered their price objective
for the company from $127.00 to $120.00 in a research report on Wednesday,
September 6th. Finally, Stifel Nicolaus increased their price objective on
shares of United Technologies from $122.00 to $124.00 and gave the company a
hold rating in a research report on Wednesday, October 25th. Thirteen equities
research analysts have rated the stock with a hold rating and six have issued a
buy rating to the stock. The company currently has an average rating of Hold
and an average price target of $125.63. Read more …
Bank of America upgraded shares of Clorox (NYSE:CLX) from an
underperform rating to a neutral rating in a report released on Thursday. Bank
of America currently has $155.00 price target on the stock. Several other
analysts also recently weighed in on CLX. Jefferies Group reaffirmed a hold
rating and issued a $130.00 target price on shares of Clorox in a report on
Wednesday, December 13th. Zacks Investment Research downgraded shares of Clorox
from a hold rating to a sell rating in a report on Wednesday, October 4th. BMO
Capital Markets reaffirmed a buy rating and issued a $150.00 target price on
shares of Clorox in a report on Thursday, October 5th. Wells Fargo & Co
reaffirmed a hold rating and issued a $130.00 target price on shares of Clorox
in a report on Wednesday, December 13th. Finally, Consumer Edge raised shares
of Clorox from a neutral rating to an outperform rating in a report on Friday,
November 10th. Two investment analysts have rated the stock with a sell rating,
eleven have assigned a hold rating and three have issued a buy rating to the
company’s stock. Clorox presently has an average rating of Hold and a consensus
target price of $133.33. Read more …
CVS Health (NYSE:CVS)‘s stock had its “buy” rating reissued
by investment analysts at Raymond James Financial in a note issued to investors
on Monday. A number of other research firms have also issued reports on CVS.
Royal Bank Of Canada assumed coverage on shares of CVS Health in a report on
Tuesday, September 19th. They set an “outperform” rating and a $95.00 target
price for the company. Jefferies Group upped their target price on shares of
CVS Health from $82.00 to $86.00 and gave the stock a “hold” rating in a report
on Friday, September 15th. Needham & Company LLC reaffirmed a “hold” rating
on shares of CVS Health in a report on Sunday, September 10th. Wolfe Research
lowered shares of CVS Health from an “outperform” rating to a “market perform”
rating and dropped their target price for the stock from $89.00 to $82.00 in a
report on Monday, August 14th. Finally, Robert W. Baird reissued an
“outperform” rating and issued a $90.00 price objective on shares of CVS Health
in a report on Monday, August 14th. One analyst has rated the stock with a sell
rating, eight have given a hold rating and fifteen have given a buy rating to
the stock. CVS Health has an average rating of “Buy” and an average target
price of $86.35. Read more …
CVS Health (NYSE:CVS) was upgraded by analysts at Morgan
Stanley from an “equal weight” rating to an “overweight” rating in a research
report issued to clients and investors on Friday. Read more …
Cisco Systems (NASDAQ:CSCO) was upgraded by equities
researchers at Bank of America from a “neutral” rating to a “buy” rating in a
note issued to investors on Friday, MarketBeat Ratings reports. The brokerage
presently has a $46.00 price objective on the network equipment provider’s
stock, up from their prior price objective of $38.99. Bank of America’s price
target indicates a potential upside of 16.25% from the company’s current price.
The analysts noted that the move was a valuation call. Other research analysts
have also issued research reports about the company. Vetr lowered Cisco Systems
from a “buy” rating to a “hold” rating and set a $34.13 price objective for the
company. in a research report on Monday, September 25th. Berenberg Bank
reaffirmed a “hold” rating and set a $33.00 price objective on shares of Cisco
Systems in a research report on Tuesday, October 24th. BMO Capital Markets reissued
a “hold” rating and issued a $32.00 target price on shares of Cisco Systems in
a report on Monday, October 23rd. Citigroup reissued a “buy” rating and issued
a $40.00 target price on shares of Cisco Systems in a report on Thursday,
November 16th. They noted that the move was a valuation call. Finally, Nomura
lifted their target price on Cisco Systems from $29.00 to $33.00 and gave the
stock a “neutral” rating in a report on Thursday, November 16th. One equities
research analyst has rated the stock with a sell rating, twelve have issued a
hold rating, twenty-two have given a buy rating and one has given a strong buy
rating to the stock. The stock currently has an average rating of “Buy” and a
consensus target price of $37.35. Read more …
Eli Lilly and (NYSE:LLY) was upgraded by equities
researchers at Argus from a “hold” rating to a “buy” rating in a report
released on Friday, The Fly reports. Other research analysts also recently
issued research reports about the stock. BMO Capital Markets set a $73.00 price
target on shares of Eli Lilly and and gave the stock a “sell” rating in a research
report on Tuesday, December 5th. Leerink Swann upped their price target on
shares of Eli Lilly and from $92.00 to $93.00 and gave the stock a “market
perform” rating in a research report on Monday, October 23rd. Jefferies Group
reiterated a “buy” rating and set a $89.00 price target on shares of Eli Lilly
and in a research report on Monday, September 11th. Piper Jaffray Companies
reiterated an “overweight” rating and set a $105.00 price target (up previously
from $103.00) on shares of Eli Lilly and in a research report on Friday,
September 8th. Finally, Credit Suisse Group reiterated a “hold” rating on
shares of Eli Lilly and in a research report on Wednesday, December 13th. Three
investment analysts have rated the stock with a sell rating, six have issued a
hold rating and ten have assigned a buy rating to the company. Eli Lilly and
presently has an average rating of “Hold” and a consensus price target of
$90.25. Read more …
Lowe's Companies (NYSE:LOW) was upgraded by Barclays from an
“equal weight” rating to an “overweight” rating in a research note issued to
investors on Friday, Marketbeat reports. LOW has been the subject of several
other research reports. Zacks Investment Research upgraded shares of Lowe's
Companies from a “sell” rating to a “hold” rating in a research note on Monday,
September 11th. BMO Capital Markets reiterated a “hold” rating and issued a
$82.00 target price on shares of Lowe's Companies in a research note on
Thursday, November 2nd. Raymond James Financial upgraded shares of Lowe's Companies
from a “market perform” rating to an “outperform” rating and set a $87.00
target price for the company in a research note on Monday, November 27th. UBS
Group upgraded shares of Lowe's Companies from a “market perform” rating to an
“outperform” rating in a research note on Monday, November 27th. Finally,
Robert W. Baird restated a “buy” rating and set a $92.00 price target (up
previously from $87.00) on shares of Lowe's Companies in a research note on
Wednesday, November 22nd. Three research analysts have rated the stock with a
sell rating, twelve have assigned a hold rating and eighteen have issued a buy
rating to the company’s stock. Lowe's Companies presently has a consensus
rating of “Hold” and an average target price of $88.62. Read more …
Downgrades:
JPMorgan Chase & Co. downgraded shares of Johnson &
Johnson (NYSE:JNJ) from an overweight rating to a neutral rating in a research
note published on Tuesday. A number of other equities research analysts also
recently commented on JNJ. Vetr upgraded Johnson & Johnson from a hold
rating to a buy rating and set a $147.40 price objective for the company in a
report on Monday. Citigroup assumed coverage on Johnson & Johnson in a
report on Monday, September 25th. They issued a neutral rating and a $140.00
price target for the company. BMO Capital Markets restated a positive rating and
issued a $152.00 price target (up from $145.00) on shares of Johnson &
Johnson in a report on Wednesday, October 18th. Jefferies Group increased their
price target on Johnson & Johnson from $157.00 to $160.00 and gave the
stock a buy rating in a report on Monday, October 16th. Finally, Royal Bank of
Canada increased their price target on Johnson & Johnson from $144.00 to
$147.00 and gave the stock an outperform rating in a report on Wednesday,
October 18th. Four equities research analysts have rated the stock with a sell
rating, seven have assigned a hold rating and eleven have given a buy rating to
the company. Johnson & Johnson has a consensus rating of Hold and an
average price target of $145.52. Read more …
Guggenheim cut shares of American Electric Power (NYSE:AEP)
from a neutral rating to a sell rating in a research report sent to investors
on Tuesday. Other research analysts have also recently issued reports about the
stock. Royal Bank of Canada reissued a hold rating and set a $74.00 price
objective on shares of American Electric Power in a research note on Monday,
October 30th. Morgan Stanley reissued an equal weight rating on shares of
American Electric Power in a research note on Friday, September 8th. Zacks
Investment Research cut shares of American Electric Power from a hold rating to
a sell rating in a research note on Tuesday, December 12th. ValuEngine raised
shares of American Electric Power from a hold rating to a buy rating in a
research note on Tuesday, November 14th. Finally, JPMorgan Chase & Co.
raised their price objective on shares of American Electric Power to $75.00 and
gave the stock a neutral rating in a research note on Thursday, October 12th.
One investment analyst has rated the stock with a sell rating, eight have issued
a hold rating and seven have given a buy rating to the stock. The company has
an average rating of Hold and an average price target of $74.82. Read more …
American Water Works (NYSE:AWK) was downgraded by Guggenheim
from a “buy” rating to a “neutral” rating in a research report issued on
Tuesday. A number of other equities research analysts have also recently
weighed in on the stock. Argus upped their price objective on shares of
American Water Works from $100.00 to $105.00 and gave the stock a “buy” rating
in a report on Friday. Zacks Investment Research upgraded shares of American
Water Works from a “hold” rating to a “buy” rating and set a $101.00 price
objective on the stock in a report on Tuesday, December 19th. Robert W. Baird
upped their price objective on shares of American Water Works from $82.00 to
$87.00 and gave the stock a “neutral” rating in a report on Friday, November
3rd. Janney Montgomery Scott cut shares of American Water Works from a “buy”
rating to a “neutral” rating in a report on Friday, November 3rd. They noted
that the move was a valuation call. Finally, Boenning Scattergood restated a
“hold” rating on shares of American Water Works in a report on Thursday,
November 2nd. Ten investment analysts have rated the stock with a hold rating
and four have given a buy rating to the company. The stock currently has an
average rating of “Hold” and a consensus target price of $90.51. Read more …
Morgan Stanley downgraded shares of Invesco (NYSE:IVZ) from
an overweight rating to an equal weight rating in a research note issued to
investors on Wednesday morning. Morgan Stanley currently has $39.00 target
price on the asset manager’s stock, down from their previous target price of
$40.00. Several other analysts have also weighed in on the company. Royal Bank
of Canada set a $47.00 price objective on Invesco and gave the stock a buy
rating in a report on Saturday, December 16th. ValuEngine raised Invesco from a
hold rating to a buy rating in a report on Wednesday, December 6th. Zacks
Investment Research lowered Invesco from a buy rating to a hold rating in a
report on Wednesday, November 29th. Jefferies Group lifted their price
objective on Invesco from $41.00 to $42.00 and gave the stock a buy rating in a
report on Friday, November 3rd. Finally, Citigroup lifted their price objective
on Invesco from $43.00 to $44.00 and gave the stock a buy rating in a report on
Friday, October 27th. One investment analyst has rated the stock with a sell
rating, five have given a hold rating and nine have assigned a buy rating to
the company. Invesco presently has an average rating of Buy and a consensus
target price of $39.17. Read more …
TJX Companies (NYSE:TJX) was downgraded by research analysts
at Wells Fargo & Co from an “outperform” rating to a “market perform”
rating in a research report issued on Wednesday. A number of other brokerages
also recently issued reports on TJX. Zacks Investment Research upgraded TJX
Companies from a “hold” rating to a “buy” rating and set a $82.00 price
objective for the company in a research note on Tuesday, October 10th. Nomura cut
their price target on TJX Companies from $80.00 to $75.00 and set a “buy”
rating for the company in a research note on Wednesday, November 15th. Morgan
Stanley cut their price target on TJX Companies from $86.00 to $85.00 and set
an “overweight” rating for the company in a research note on Wednesday,
November 15th. Royal Bank of Canada set a $70.00 price target on TJX Companies
and gave the stock an “outperform” rating in a research note on Tuesday,
November 14th. Finally, Jefferies Group reiterated a “hold” rating and set a
$75.00 price target on shares of TJX Companies in a research note on Thursday,
September 28th. One analyst has rated the stock with a sell rating, four have
issued a hold rating and sixteen have assigned a buy rating to the stock. The
company presently has an average rating of “Buy” and an average price target of
$82.15. Read more …
Bank of America cut shares of Chevron (NYSE:CVX) from a buy
rating to a neutral rating in a research note released on Thursday. They
currently have $125.00 price target on the oil and gas company’s stock. The
analysts noted that the move was a valuation call. A number of other brokerages
also recently issued reports on CVX. Vetr upgraded shares of Chevron from a
hold rating to a buy rating and set a $134.35 price target for the company in a
research note on Tuesday, December 26th. Zacks Investment Research upgraded
shares of Chevron from a hold rating to a buy rating and set a $140.00 price
target for the company in a research note on Wednesday, December 27th.
Scotiabank reiterated a buy rating and issued a $130.00 price target on shares
of Chevron in a research note on Friday, December 22nd. Jefferies Group restated
a buy rating and set a $140.00 price objective on shares of Chevron in a
research report on Wednesday, December 20th. Finally, Royal Bank of Canada set
a $110.00 price objective on shares of Chevron and gave the stock a sell rating
in a research report on Wednesday, December 20th. Three analysts have rated the
stock with a sell rating, nine have assigned a hold rating and fifteen have
given a buy rating to the company’s stock. The company has an average rating of
Hold and a consensus price target of $125.15. Read more …





















No comments:
Post a Comment